Primary malignant lymphoma of the brain: Mutation pattern of rearranged immunoglobulin heavy chain gene

Japanese Journal of Cancer Research

Volumn 93, Issue 12, 2002, Pages 1308-1316

  Endo, Sumio ^a   Zhang, Shu Jing ^b   Saito, Takafumi ^c   Kouno, Mitsuo ^d   Kuroiwa, Toshihiko ^e   Washiyama, Kazuo ^a   Kumanishi, Toshiro ^a,f  

^a NIIGATA UNIVERSITY   (Japan)

^b KAROLINSKA INSTITUTE   (Sweden)

^c NAGANO RED CROSS HOSPITAL   (Japan)

^d TOYAMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^e OSAKA MEDICAL COLLEGE   (Japan)

^f Niigata Longevity Research Institute   (Japan)

Author keywords

B cell lymphoma; Brain lymphoma; Immunoglobulin gene; In situ hybridization; Lymphoma

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; OLIGONUCLEOTIDE;

ADULT; AGED; B CELL LYMPHOMA; BRAIN LYMPHOMA; CLINICAL ARTICLE; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GERMINAL CENTER; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; MOLECULAR CLONING; MOLECULAR PROBE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SEQUENCE ANALYSIS; SOMATIC MUTATION;

EID: 0036949513     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2002.tb01239.x     Document Type: Review

References (42)

1. Russell, D. S. and Rubinstein, L. J. "Pathology of the Tumours of the Nervous System," 5th Ed., pp. 590-638 (1989). Edward Arnold, London.
2. Hayakawa, T., Takakura, K., Abe, H., Yoshimoto, T., Tanaka, R., Sugita, K., Kikuchi, H., Uozumi, T., Hori, T., Fukui, H., Ushio, Y., Nomura, K., Matsutani, M., Mohri, N., Kumanishi, T., Aozasa, K. and Nagashima, K. Primary central nervous system lymphoma in Japan - a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan. J Neurooncol., 19, 197-215 (1994).
3. Kumanishi, T., Washiyama, K., Saito, T., Nishiyama, A., Abe, S. and Tanaka, R. Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies. Acta Neuropathol., 71, 190-196 (1986).
4. Kumanishi, T., Washiyama, K., Nishiyama, A., Abe, S., Saito, T. and Ichikawa, T. Primary malignant lymphoma of the brain: demonstration of immunoglobulin gene rearrangements in four cases by the Southern blot hybridization technique. Acta Neuropathol., 79, 23-26 (1989).
5. Kleihues, P. and Cavenee, W. K. "Pathology and Genetics of Tumours of the Nervous System," pp. 198-203 (2000). IARC Press, Lyon.
6. Zhang, S.-J., Endo, S., Ichikawa, T., Washiyama, K. and Kumanishi, T. Frequent deletion and 5′ CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Cancer Res., 58, 1231-1237 (1998).
7. Koga, H., Zhang, S.-J., Ichikawa, T., Washiyama, K., Kuroiwa, T., Tanaka, R. and Kumanishi, T. Primary malignant lymphoma of the brain: demonstration of the p53 gene mutation by PCR-SSCP analysis and immunohistochemistry. Brain Tumor Pathol., 11, 151-155 (1994).
8. Nishiyama, A., Saito, T., Abe, S. and Kumanishi, T. An immunohistochemical analysis of T cells in primary B cell malignant lymphoma of the brain. Acta Neuropathol., 79, 27-29 (1989).
9. Tonegawa, S. Somatic generation of antibody diversity. Nature, 302, 575-581 (1983).
10. Rajewsky, K. Clonal selection and learning in the antibody system. Nature, 381, 751-758 (1996).
11. H fusions. Proc. Natl. Acad. Sci. USA, 79, 4118-4122 (1982).
12. Alt, F. W., Blackwell, T. K. and Yancopouisos, G. D. Development of the primary antibody repertoire. Science, 238, 1079-1087 (1987).
13. Jacob, J., Kelsoe, G., Rajewsky, K. and Weiss, U. Intraclonal generation of antibody mutants in germinal centres. Nature, 354, 389-392 (1991).
14. Berek, C., Berger, A. and Apel, M. Maturation of the immune response in germinal centers. Cell, 67, 1121-1129 (1991).
15. Küppers, R., Zhao, M., Hansmann, M.-L. and Rajewsky, K. Tracing B cell development in human germinal centres by molecular analysis of single cells picked from histological sections. EMBO J., 12, 4955-4967 (1993).
16. Klein, U., Goossens, T., Fischer, M., Kanzler, H., Braeuninger, A., Rajewsky, K. and Küppers, R. Somatic hypermutation in normal and transformed human B cells. Immunol. Rev., 162, 261-280 (1998).
17. H4 Ig gene family by diffuse large-cell lymphoma. Blood, 86, 3072-3082 (1995).
18. Küppers, R., Rajewsky, K. and Hansmann, M.-L. Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression. Eur. J. Immunol., 27, 1398-1405 (1997).
19. Lossos, I. S., Okada, C. Y., Tibshirani, R., Warnke, R., Vose, J. M., Greiner, T. C. and Levy, R. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood, 95, 1797-1803 (2000).
20. Bahler, D. W. and Levy, R. Clonal evolution of a follicular lymphoma: evidence for antigen selection. Proc. Natl. Acad. Sci. USA, 89, 6770-6774 (1992).
21. Matolcsy, A., Schattner, E. J., Knowles, D. M. and Casali, P. Clonal evolution of B cells in transformation from low-to high-grade lymphoma. Eur. J. Immunol., 29, 1253-1264 (1999).
22. Lossos, I. S., Alizadeh, A. A., Eisen, M. B., Chan, W. C., Brown, P. O., Botstein, D., Staudt, L. M. and Levy, R. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc. Natl. Acad. Sci. USA, 97, 10209-10213 (2000).
23. H genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression. Blood, 91, 4292-4299 (1998).
24. H gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity. Blood, 94, 1738-1746 (1999).
25. Montesinos-Rongen, M., Küppers, R., Schlüter, D., Spieker, T., Roost, D. V., Schaller, C., Reifenberger, G., Wiestler, O. D. and Deckert-Schlüter, M. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment. Am. J. Pathol., 155, 2077-2086 (1999).
26. Suci, T., Tajima, K., Nanba, K., Wakasa, H., Mikata, A., Kikuchi, M., Mori, S., Watanabe, S., Mohri, N., Shamoto, M., Harigaya, K., Itagaki, T., Matsuda, M., Kirino, Y., Takagi, K. and Fukunaga, S. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma-a proposal of a new type. Acta Pathol. Jpn., 29, 755-776 (1979).
27. The non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. Cancer, 49, 2112-2135 (1982).
28. Harris, N. L., Jaffe, E.S., Stein, H., Banks, P.M., Chan, J.K. C., Cleary, M. L., Delsol, G., De Wolf-Peeters, C., Falini, B., Gatter, K. C., Grogan, T. M., Isaacson, P. G., Knowles, D. M., Mason, D. Y., Muller-Hermelink, H.-K., Pileri, S. A., Piris, M. A., Ralfkiaer, E. and Warnke, R. A. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 84, 1361-1392 (1994)
29. H4-34) gene. Blood, 87, 2846-2852 (1996).
30. Kumanishi, T., Zhang, S., Ichikawa, T., Endo, S. and Washiyama, K. Primary malignant lymphoma of the brain: demonstration of frequent p16 and p15 gene deletions. Jpn. J. Cancer Res., 87, 691-695 (1996).
31. Sanger, F., Nicklen, S., and Coulson, A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USAm 74, 546305467 (1977).
32. Lefranc, M.-P. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res., 29, 207-209 (2001).
33. H genes are inherently susceptible to amino acid replacement. Immunol. Today, 15, 367-373 (1994).
34. Katagiri, T., Feng, X.-L., Ichikawa, T., Usui, H., Takahashi, Y. and Kumanishi, T. Neuron-specific enolase (NSE) and non-neuronal enolase (NNE) mRNAs are co-expressed in neurons of the rat cerebellum: in situ hybridization histochemistry. Brain Res. Mol. Brain Res., 19, 1-8 (1993).
35. Taylor, J. M. E., Spagnolo, D. V. and Kay, P. H. B-Cell target DNA quantity is a critical factor in the interpretation of B-cell clonality by PCR. Pathology, 29, 309-312 (1997).
36. Diaz-Cano, S. PCR-based alternative for diagnosis of immunoglobulin heavy chain gene rearrangement. Diagn. Mol. Pathol., 5, 3-9 (1996).
37. Rockman, S. P. Determination of clonality in patients who present with diagnostic dilemmas: a laboratory experience and review of the literature. Leukemia, 11, 852-862 (1997).
38. Macintyre, E. A. and Delabesse, E. Molecular approaches to the diagnosis and evaluation of lymphoid malignancies. Semin. Hematol., 36, 373-389 (1999).
39. Diss, T. C. and Pan, L. Polymerase chain reaction in the assessment of lymphomas. Cancer Surv., 30, 21-44 (1997).
40. Kersten, M. J., Evers, L. M., Dellemijn, P. L., van den Berg, H., Portegies, P., Hintzen, R. Q., van Lier, R. A., vondem Borne, A. E. and van Oers, R. H. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood, 87, 1985-1989 (1996).
41. Murase, S., Saio, M., Andoh, H., Takenaka, K., Shinoda, J., Nishimura, Y., Sakai, N. and Takami, T. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients. Neurol. Res., 22, 434-442 (2000).
42. Arai, T., Nagai, M. and Okuhata, S. Immunophenotypic analysis of primary malignant lymphoma of the brain. Neurol. Med. Chir. (Tokyo), 34, 136-142 (1994).